Depending on the nature of claims, we are always aware of the risk for class actions to arise in the context
of product liability actions.
He has defended hundreds
of product liability actions in state and federal courts throughout the United States relating to a wide range of consumer and commercial products, and has in - depth experience with commercial food equipment, aviation components, and specialty plastics.
Her practice includes the defense
of product liability actions, including those involving pharmaceutical and vehicular products, among others, the prosecution and defense of negligence actions, including malpractice actions, the defense of toxic tort and environmental actions, the representation of creatives and entertainment companies in contract negotiations, contractual disputes, and other disputes, and the representation of employers in labor matters.
His environmental and tort litigation experience includes dozens
of products liability actions in California State and Federal District Courts and multi-district litigation proceedings in the Southern District of New York that arise out of MTBE contamination of drinking water aquifers, as well as actions brought under the Comprehensive Environmental Response, Compensation and Liability Act («CERCLA»), the Resource Conservation and Recovery Act («RCRA»), California Proposition 65, the Clean Air Act, and various state and federal criminal laws, environmental laws, or tort doctrines.
A person who has been injured by such a product may be entitled to recover damages from certain parties involved in the product's production and release to the public through the institution
of a product liability action.
A person who has been injured as a result of a product defect may be able to recover damages from the product's manufacturer and others through the institution
of a product liability action.
Not exact matches
Important factors that could cause actual results to differ materially from those reflected in such forward - looking statements and that should be considered in evaluating our outlook include, but are not limited to, the following: 1) our ability to continue to grow our business and execute our growth strategy, including the timing, execution, and profitability
of new and maturing programs; 2) our ability to perform our obligations under our new and maturing commercial, business aircraft, and military development programs, and the related recurring production; 3) our ability to accurately estimate and manage performance, cost, and revenue under our contracts, including our ability to achieve certain cost reductions with respect to the B787 program; 4) margin pressures and the potential for additional forward losses on new and maturing programs; 5) our ability to accommodate, and the cost
of accommodating, announced increases in the build rates
of certain aircraft; 6) the effect on aircraft demand and build rates
of changing customer preferences for business aircraft, including the effect
of global economic conditions on the business aircraft market and expanding conflicts or political unrest in the Middle East or Asia; 7) customer cancellations or deferrals as a result
of global economic uncertainty or otherwise; 8) the effect
of economic conditions in the industries and markets in which we operate in the U.S. and globally and any changes therein, including fluctuations in foreign currency exchange rates; 9) the success and timely execution
of key milestones such as the receipt
of necessary regulatory approvals, including our ability to obtain in a timely fashion any required regulatory or other third party approvals for the consummation
of our announced acquisition
of Asco, and customer adherence to their announced schedules; 10) our ability to successfully negotiate, or re-negotiate, future pricing under our supply agreements with Boeing and our other customers; 11) our ability to enter into profitable supply arrangements with additional customers; 12) the ability
of all parties to satisfy their performance requirements under existing supply contracts with our two major customers, Boeing and Airbus, and other customers, and the risk
of nonpayment by such customers; 13) any adverse impact on Boeing's and Airbus» production
of aircraft resulting from cancellations, deferrals, or reduced orders by their customers or from labor disputes, domestic or international hostilities, or acts
of terrorism; 14) any adverse impact on the demand for air travel or our operations from the outbreak
of diseases or epidemic or pandemic outbreaks; 15) our ability to avoid or recover from cyber-based or other security attacks, information technology failures, or other disruptions; 16) returns on pension plan assets and the impact
of future discount rate changes on pension obligations; 17) our ability to borrow additional funds or refinance debt, including our ability to obtain the debt to finance the purchase price for our announced acquisition
of Asco on favorable terms or at all; 18) competition from commercial aerospace original equipment manufacturers and other aerostructures suppliers; 19) the effect
of governmental laws, such as U.S. export control laws and U.S. and foreign anti-bribery laws such as the Foreign Corrupt Practices Act and the United Kingdom Bribery Act, and environmental laws and agency regulations, both in the U.S. and abroad; 20) the effect
of changes in tax law, such as the effect
of The Tax Cuts and Jobs Act (the «TCJA») that was enacted on December 22, 2017, and changes to the interpretations
of or guidance related thereto, and the Company's ability to accurately calculate and estimate the effect
of such changes; 21) any reduction in our credit ratings; 22) our dependence on our suppliers, as well as the cost and availability
of raw materials and purchased components; 23) our ability to recruit and retain a critical mass
of highly - skilled employees and our relationships with the unions representing many
of our employees; 24) spending by the U.S. and other governments on defense; 25) the possibility that our cash flows and our credit facility may not be adequate for our additional capital needs or for payment
of interest on, and principal
of, our indebtedness; 26) our exposure under our revolving credit facility to higher interest payments should interest rates increase substantially; 27) the effectiveness
of any interest rate hedging programs; 28) the effectiveness
of our internal control over financial reporting; 29) the outcome or impact
of ongoing or future litigation, claims, and regulatory
actions; 30) exposure to potential
product liability and warranty claims; 31) our ability to effectively assess, manage and integrate acquisitions that we pursue, including our ability to successfully integrate the Asco business and generate synergies and other cost savings; 32) our ability to consummate our announced acquisition
of Asco in a timely matter while avoiding any unexpected costs, charges, expenses, adverse changes to business relationships and other business disruptions for ourselves and Asco as a result
of the acquisition; 33) our ability to continue selling certain receivables through our supplier financing program; 34) the risks
of doing business internationally, including fluctuations in foreign current exchange rates, impositions
of tariffs or embargoes, compliance with foreign laws, and domestic and foreign government policies; and 35) our ability to complete the proposed accelerated stock repurchase plan, among other things.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its
products from other brands; the consolidation
of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key
product categories, increase its market share, or add
products; an impairment
of the carrying value
of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution
of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement
actions;
product recalls or
product liability claims; unanticipated business disruptions; failure to successfully integrate the Company; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility
of capital markets; increased pension, labor and people - related expenses; volatility in the market value
of all or a portion
of the derivatives that the Company uses; exchange rate fluctuations; disruptions in information technology networks and systems; the Company's inability to protect intellectual property rights; impacts
of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's dividend payments on its Series A Preferred Stock; tax law changes or interpretations; pricing
actions; and other factors.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, operating in a highly competitive industry; changes in the retail landscape or the loss
of key retail customers; the Company's ability to maintain, extend and expand its reputation and brand image; the impacts
of the Company's international operations; the Company's ability to leverage its brand value; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key
product categories, increase its market share, or add
products; an impairment
of the carrying value
of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's ability to realize the anticipated benefits from its cost savings initiatives; changes in relationships with significant customers and suppliers; the execution
of the Company's international expansion strategy; tax law changes or interpretations; legal claims or other regulatory enforcement
actions;
product recalls or
product liability claims; unanticipated business disruptions; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the United States and in various other nations in which we operate; the volatility
of capital markets; increased pension, labor and people - related expenses; volatility in the market value
of all or a portion
of the derivatives we use; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation
of data or breaches
of security; the Company's ability to protect intellectual property rights; impacts
of natural events in the locations in which we or the Company's customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; the Company's ownership structure; the impact
of future sales
of its common stock in the public markets; the Company's ability to continue to pay a regular dividend; changes in laws and regulations; restatements
of the Company's consolidated financial statements; and other factors.
Important factors that may affect the Company's business and operations and that may cause actual results to differ materially from those in the forward - looking statements include, but are not limited to, increased competition; the Company's ability to maintain, extend and expand its reputation and brand image; the Company's ability to differentiate its
products from other brands; the consolidation
of retail customers; the Company's ability to predict, identify and interpret changes in consumer preferences and demand; the Company's ability to drive revenue growth in its key
product categories, increase its market share or add
products; an impairment
of the carrying value
of goodwill or other indefinite - lived intangible assets; volatility in commodity, energy and other input costs; changes in the Company's management team or other key personnel; the Company's inability to realize the anticipated benefits from the Company's cost savings initiatives; changes in relationships with significant customers and suppliers; execution
of the Company's international expansion strategy; changes in laws and regulations; legal claims or other regulatory enforcement
actions;
product recalls or
product liability claims; unanticipated business disruptions; failure to successfully integrate the business and operations
of the Company in the expected time frame; the Company's ability to complete or realize the benefits from potential and completed acquisitions, alliances, divestitures or joint ventures; economic and political conditions in the nations in which the Company operates; the volatility
of capital markets; increased pension, labor and people - related expenses; volatility in the market value
of all or a portion
of the derivatives that the Company uses; exchange rate fluctuations; risks associated with information technology and systems, including service interruptions, misappropriation
of data or breaches
of security; the Company's inability to protect intellectual property rights; impacts
of natural events in the locations in which the Company or its customers, suppliers or regulators operate; the Company's indebtedness and ability to pay such indebtedness; tax law changes or interpretations; and other factors.
Many factors could cause BlackBerry's actual results, performance or achievements to differ materially from those expressed or implied by the forward - looking statements, including, without limitation: BlackBerry's ability to enhance its current
products and services, or develop new
products and services in a timely manner or at competitive prices, including risks related to new
product introductions; risks related to BlackBerry's ability to mitigate the impact
of the anticipated decline in BlackBerry's infrastructure access fees on its consolidated revenue by developing an integrated services and software offering; intense competition, rapid change and significant strategic alliances within BlackBerry's industry; BlackBerry's reliance on carrier partners and distributors; risks associated with BlackBerry's foreign operations, including risks related to recent political and economic developments in Venezuela and the impact
of foreign currency restrictions; risks relating to network disruptions and other business interruptions, including costs, potential
liabilities, lost revenues and reputational damage associated with service interruptions; risks related to BlackBerry's ability to implement and to realize the anticipated benefits
of its CORE program; BlackBerry's ability to maintain or increase its cash balance; security risks; BlackBerry's ability to attract and retain key personnel; risks related to intellectual property rights; BlackBerry's ability to expand and manage BlackBerry ® World ™; risks related to the collection, storage, transmission, use and disclosure
of confidential and personal information; BlackBerry's ability to manage inventory and asset risk; BlackBerry's reliance on suppliers
of functional components for its
products and risks relating to its supply chain; BlackBerry's ability to obtain rights to use software or components supplied by third parties; BlackBerry's ability to successfully maintain and enhance its brand; risks related to government regulations, including regulations relating to encryption technology; BlackBerry's ability to continue to adapt to recent board and management changes and headcount reductions; reliance on strategic alliances with third - party network infrastructure developers, software platform vendors and service platform vendors; BlackBerry's reliance on third - party manufacturers; potential defects and vulnerabilities in BlackBerry's
products; risks related to litigation, including litigation claims arising from BlackBerry's practice
of providing forward - looking guidance; potential charges relating to the impairment
of intangible assets recorded on BlackBerry's balance sheet; risks as a result
of actions of activist shareholders; government regulation
of wireless spectrum and radio frequencies; risks related to economic and geopolitical conditions; risks associated with acquisitions; foreign exchange risks; and difficulties in forecasting BlackBerry's financial results given the rapid technological changes, evolving industry standards, intense competition and short
product life cycles that characterize the wireless communications industry.
Notwithstanding anything to the contrary herein, if Thing Daemon believes in its discretion that your sale or any
products, services, content or other materials in the listing or on Thing Daemon's servers may create
liability for Thing Daemon or harm other users
of the Services, then you agree that Thing Daemon may take any
actions with respect to the content or materials or listing that Thing Daemon believes are prudent or necessary to minimize or eliminate our potential
liability or to protect other users
of our Services.
You shall indemnify The Endocrine Society and its directors, officers, employees, agents, contractors and licensors («The Endocrine Society Indemnitees») against all claims,
actions, suits, and other proceedings («Claims») arising out
of or incurred in connection with the Site and your use
of the Site, your fraud, violation
of law, negligence, willful misconduct, or any other use
of the Site, the User Materials, the Site Materials, the services,
products, information and other materials on and in and made available through the Site, (except to the extent attributable to The Endocrine Society), or any breach by you
of these Terms and Conditions and shall indemnify and hold the Endocrine Society Indemnitees harmless from and against all judgments, losses,
liabilities, damages, costs, and expenses (including without limitation reasonable attorneys» fees and attorneys» disbursements) arising out
of or incurred in connection with such Claims.
ACX does not assume any responsibility or
liability for the
actions,
product, and content
of all these and any
of these sites.
Product liability litigation is often the preserve
of plaintiff class
action lawyers and large Bay Street defence firms, not Main Street law firms.
If a defect in a
product is found to have been a cause
of a child's flame - burn injury, the manufacturer
of the
product and anyone in the chain
of the
product's distribution may be found liable for the injuries suffered by the child in a
product -
liability action.
The firm's Alaska
products liability defense attorneys will determine the most effective course
of action to handle each case.
Brendan has acted on a wide range
of insurance and reinsurance matters for Australian - based and international clients, including flooding, storm, earthquake, fire and explosion events, electricity supply issues and machinery break - downs, as well as high - value class
action litigation, public and
product liability, and subrogation claims.
Many
of the patients affected by NSF / NSD have filed gadolinium lawsuits or joined class
action gadolinium lawsuits claiming that the manufacturers
of gadolinium - based contrast agents were negligent or violated
product liability and / or pharmaceutical
liability statutes.
She focuses her practice on complex business litigation and arbitration, including class
action defense, breach
of contract,
product liability, and fraud.
We fight for the rights
of those who are the victims
of personal injury, wrongful death, slip and fall, dog and other animal bites, car accidents, tractor trailer accidents, pedestrian injuries, medical malpractice claims, drug claims, healthcare injuries, nursing home abuse and neglect, Workmen's Compensation, Social Security disability, defective
product /
product liability, and consumer class
action causes / consumer fraud.
William also has an interest in medical
product liability claims, having acted in several group
actions (including the Oral Contraceptive Pill, MMR and Depuy Hylamer prosthetic implants cases) and has advised in relation to various medical and surgical
products, including the use
of transvaginal mesh.
Tom practices in the area
of civil litigation focusing on corporate / commercial litigation, securities litigation,
product liability defence and class
action defence.
His practice covers a range
of litigation, including commercial, class
action defense,
product liability, mass tort, environmental, trade secret, insurance coverage, and real property title disputes in state and federal courts.
The manufacturer
of a
product that contains a defect in the
product's manufacture or design or as a result
of the manufacturer's or seller's failure to warn
of the
product's dangers may be held liable in a
product liability action for injuries sustained by a child as a result
of the child's use
of or exposure to the
product.
With deep experience in
product liability matters and class
action litigation, including catastrophic injury and wrongful death cases, as well as consumer fraud, he represents national and international companies, including manufacturers
of motor vehicles, power tools, pharmaceuticals, clothing, glass
products, outdoor power equipment, and industrial machinery.
Supreme Court Limits Federal Courts» Power to Enjoin Class
Actions In State Courts - Highlighting the Importance
of CAFA -
Product Liability Update
Our attorneys represent clients in a wide variety
of practice areas, such as car accidents, medical malpractice,
product liability, workers» compensation, labor and employment, class
action lawsuits, and more.
The consumer goods will be vulnerable to
product liability lawsuit unless distributors, manufacturers, and sellers take proper
action concerning the safety
of the children's
products they produce and sell to the customers.
He has represented a broad spectrum
of clients in
products liability and class
action matters, breach
of warranty claims, wrongful death claims, tort and personal injury claims, professional
liability claims and other areas
of civil litigation.
In either case, the manufacturer
of the defective shield or grate and anyone in the chain
of the
product's distribution may be held liable in a
product -
liability action for the flame - burn injuries suffered by the child as a result
of the defect.
GM Recall Highlights Importance
of Timely Reporting and Corrective
Action -
Product Liability Update
V Andre Sherman is a trial lawyer specializing in the areas
of product liability, pharmaceutical mass torts, consumer and employment class
actions, and business litigation.
Because the plaintiff's own experts conceded that there are no studies, even today, that purport to demonstrate that PCBs volatilize at levels capable
of causing human disease, the Court concluded that the plaintiff failed to establish any viable
products liability cause
of action.
Stephen A. LeClainche,
Of Counsel at the firm, was selected for inclusion in the fields of Product Liability Litigation, Personal Injury Litigation and Mass Tort Litigation / Class Actions for the Plaintiffs practic
Of Counsel at the firm, was selected for inclusion in the fields
of Product Liability Litigation, Personal Injury Litigation and Mass Tort Litigation / Class Actions for the Plaintiffs practic
of Product Liability Litigation, Personal Injury Litigation and Mass Tort Litigation / Class
Actions for the Plaintiffs practice.
Leslie M. Kroeger, a Partner at the firm, was selected for inclusion in the fields
of Product Liability Litigation and Mass Tort Litigation / Class
Actions for the Plaintiffs practice.
In a complex
products liability action involving alleged PCB contamination
of a state office building, the Appellate Practice Group joined forces with litigation counsel to convert a $ 60 million judgment to a defense verdict for a large, multinational company.
If a defective
product is found to have been a cause
of a fetus's death, the manufacturer
of the
product and anyone in the chain
of the
product's distribution may be found liable in a
product -
liability action for the fetus's death.
We routinely handle cases in areas
of law such as catastrophic / excess
liability; ERISA; class
actions; construction practices; general commercial litigation; insurance coverage and bad faith; insurance fraud; insurance professional
liability; life health and disability; medical professional
liability;
product liability; subrogation; and toxic and environmental torts.
Corey Brady is an associate in Weil's Complex Commercial Litigation practice, where he focuses on litigating a wide variety
of disputes, including class
actions,
product liability and environmental claims, and bankruptcy and restructuring engagements.
During his 21 - year legal career, Mr. Goldberg has litigated hundreds
of cases in federal and state courts throughout the United States involving claims
of retaliation, discrimination, wrongful termination, fraud, defamation, breach
of fiduciary duty, and breach
of contract, as well as commercial contract disputes, civil RICO, ERISA, trade secrets and restrictive covenants, corporate governance disputes, minority shareholder disputes, partnership disputes, Madoff counseling and defense, advancement and indemnification proceedings, whistleblower
actions (SOX and CEPA), executive compensation counseling, litigation, and arbitration, international litigation and arbitration, antitrust litigation and arbitration,
products liability litigation, environmental and toxic tort litigation, and securities fraud.
«As you can imagine, the incidence
of class
actions in Canada is not going to decrease as time goes on,» says Korbak, whose work also involves franchise law,
product liability and general corporate commercial law.
It is fashionable for class counsel to plead «waiver
of tort» as a common issue alleged to be certifiable in
product liability class
actions.
Lawrence Theall, a Toronto lawyer and co-author
of a legal text on
product liability in Canada, says he thinks that proposed class
actions, such as the Vitaminwater case, are less likely to succeed in our courts.
Has developed a strong track record for its handling
of prominent group
actions, including
product liability cases.»
$ 10 million recovered in a
products liability action for the wrongful death
of a spouse due to defective tire design.
Mr. Cacace has represented clients in a wide range
of matters in state and federal trial and appellate courts, including business litigation, intellectual property disputes,
product liability actions, consumer class
actions, and real estate disputes.
Our trials have covered the spectrum
of the types
of cases which we handle, including toxic torts,
product liability, consumer fraud, business and communications cases and class
actions.
He has extensive experience handling diverse areas
of complex litigation, including health care, antitrust and business practices, class
actions, qui tam claims, employment,
product liability, environmental and data security.
Attorneys in our Class
Action Practice represent «household name» corporations in defense
of consumer and false advertising class
actions; Big Four accounting firms and corporate issuers in securities class
actions; companies who have been accused
of improperly disclosing customer data; employers alleged to have violated labor and employment laws; and industrial manufacturers in
products liability class and mass tort
actions, among others.